Regeneron Pharmaceuticals, Inc. (BVL:REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BVL:REGN has a market cap or net worth of PEN 272.12 billion. The enterprise value is 218.92 billion.

Market Cap	272.12B
Enterprise Value	218.92B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	100.80M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	98.55M

Valuation Ratios

The trailing PE ratio is 17.96 and the forward PE ratio is 16.40.

PE Ratio	17.96
Forward PE	16.40
PS Ratio	5.64
PB Ratio	2.59
P/TBV Ratio	2.70
P/FCF Ratio	19.82
P/OCF Ratio	16.25
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.27, with an EV/FCF ratio of 15.95.

EV / Earnings	14.45
EV / Sales	4.56
EV / EBITDA	15.27
EV / EBIT	17.67
EV / FCF	15.95

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.10.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.10
Debt / EBITDA	0.69
Debt / FCF	0.73
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.54%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.54%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.13M
Profits Per Employee	983,477
Employee Count	15,410
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, BVL:REGN has paid 2.44 billion in taxes.

Income Tax	2.44B
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has increased by +8.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.35%
50-Day Moving Average	737.73
200-Day Moving Average	678.29
Relative Strength Index (RSI)	73.21
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.31

Income Statement

In the last 12 months, BVL:REGN had revenue of PEN 48.25 billion and earned 15.16 billion in profits. Earnings per share was 139.55.

Revenue	48.25B
Gross Profit	21.50B
Operating Income	12.45B
Pretax Income	17.60B
Net Income	15.16B
EBITDA	14.28B
EBIT	12.45B
Earnings Per Share (EPS)	139.55

Balance Sheet

The company has 28.95 billion in cash and 10.00 billion in debt, with a net cash position of 53.47 billion.

Cash & Cash Equivalents	28.95B
Total Debt	10.00B
Net Cash	53.47B
Net Cash Per Share	n/a
Equity (Book Value)	105.15B
Book Value Per Share	1,024.90
Working Capital	45.93B

Cash Flow

In the last 12 months, operating cash flow was 16.75 billion and capital expenditures -3.02 billion, giving a free cash flow of 13.73 billion.

Operating Cash Flow	16.75B
Capital Expenditures	-3.02B
Free Cash Flow	13.73B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 12.61, which amounts to a dividend yield of 1.71%.

Dividend Per Share	12.61
Dividend Yield	1.71%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	9.04%
Buyback Yield	5.65%
Shareholder Yield	7.36%
Earnings Yield	5.57%
FCF Yield	5.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVL:REGN has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4